Francisco Leon - 22 Dec 2022 Form 4 Insider Report for Provention Bio, Inc.

Role: Chief Scientific Officer
Signature: /s/ Thierry Chauche, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 22 Dec 2022
Net transactions value: -$14,574
Form type: 4
Filing time: 27 Dec 2022, 16:51:58 UTC
Previous filing: 09 Dec 2022
Next filing: 29 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVB	Common Stock	Options Exercise	$3,920	+1,568	+0.1%	$2.50^*	1,574,568	22 Dec 2022	Direct
transaction	PRVB	Common Stock	Sale	$15,681	-1,568	-0.1%	$10.00	1,573,000	22 Dec 2022	Direct	F1
transaction	PRVB	Common Stock	Options Exercise	$938	+375	+0.02%	$2.50^*	1,573,375	23 Dec 2022	Direct
transaction	PRVB	Common Stock	Sale	$3,750	-375	-0.02%	$10.00	1,573,000	23 Dec 2022	Direct
holding	PRVB	Common Stock						1,000,000	22 Dec 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVB	Stock Option (right to buy)	Options Exercise	$0	-1,568	-0.29%	$0.000000	540,152	22 Dec 2022	Common Stock	1,568	$2.50	Direct	F2
transaction	PRVB	Stock Option (right to buy)	Options Exercise	$0	-375	-0.07%	$0.000000	539,777	23 Dec 2022	Common Stock	375	$2.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.005 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
F2	The option is fully vested.

Content

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.005 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

The option is fully vested.